Prudential posts 11% profit growth in 2024, eyes over 10% growth in 2025 Investing.com -- UK-based financial services group Prudential PLC (LON:PRU) on Thursday reported its full-year 2024 financial results, indicating growth and progress towards its 2027 strategic objectives. The company's new business profit rose by 11% to $3,078 million, while its operating free surplus from in-force insurance and asset management business remained steady at $2,642 million. Prudential's adjusted operating profit before tax saw a 10% increase to $3,129 million, and the adjusted operating profit after tax rose by 7% to $2,582 million, the company said in a statement, adding that its earnings per share based on the adjusted operating profit were 89.7 cents per share, an 8% increase from 2023. The company's Group EEV equity stood at $44.2 billion, and it maintained a strong capital position with a free surplus ratio of 234%. It completed $1,045 million in share buybacks under its $2 billion program announced in June 2024, which is now expected to finish by the end of 2025. Prudential's total dividend for 2024 was 23.13 cents per share, a 13% increase, and the total shareholder returns for FY24 were $1.4 billion. The company also announced its 2024 second interim dividend of 16.29 US cents per ordinary share. Looking ahead to 2025, Prudential expects to grow its new business profit, basic earnings per share based on adjusted operating profit, and operating free surplus generated from in-force insurance and asset management business by more than 10%. The company also anticipates a minimum 10% increase in the dividend per share. Prudential is confident in achieving its 2027 financial and strategic objectives, aiming to generate sustainable value for its shareholders and other stakeholders. "In our view, the most important development is that Prudential is guiding to >10% growth in 2025 for all key metrics; new business profit, operating profit, free surplus, and dividend. Further, the ongoing $2bn buyback has been accelerated, with management expecting to complete this in 2025, rather than 2026," Jefferies analysts said in a note. Seperately, the company on Thursday also announced its intention to establish a joint venture with India's Vama Sundari Investments (Delhi) Private Limited, part of the HCL Group, to launch a standalone health insurance operation in the country. The joint venture, contingent on regulatory approval, will see Prudential Group Holdings Limited, a subsidiary of Prudential plc, acquire a 70% stake, while Vama will retain the remaining 30%, the firm said in a separate press release. Story Continues Related Articles Prudential posts 11% profit growth in 2024, eyes over 10% growth in 2025 Exclusive-Air India in talks for dozens of new widebody jets from Airbus, Boeing, sources say Indonesia stocks higher at close of trade; IDX Composite Index up 1.19% View Comments
Prudential posts 11% profit growth in 2024, eyes over 10% growth in 2025
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...